Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
AIDS
; 31(1): 147-157, 2017 01 02.
Article
in En
| MEDLINE
| ID: mdl-27776039
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
Stavudine
/
Antiretroviral Therapy, Highly Active
/
Anti-Retroviral Agents
/
Drug Substitution
Type of study:
Guideline
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Country/Region as subject:
Africa
Language:
En
Journal:
AIDS
Journal subject:
SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS)
Year:
2017
Document type:
Article
Country of publication:
United kingdom